. . . . . . . "[In HCC patients treated with IFN-?/5-FU therapy, the PRKAG2 mRNA level in HCC tissues was positively correlated with survival period, suggesting that PRKAG2 enhances the effect of IFN-?/5-FU and serves as a prognostic marker for IFN-?/5-FU therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:31+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .